ABSTRACT
Aims To investigate the characteristics of the macular structure and foveal pit in eyes with lesions and healthy fellow eyes of patients with unilateral full-thickness macular holes (FTMH).
Methods Patients with unilateral FTMH were retrospectively enrolled as the study group, and their age- and sex-matched individuals with no vitreomacular diseases as the control group in a medical center. FTMHs were classified as FTMH with lamellar hole-associated epiretinal proliferation (LHEP), FTMH without LHEP or FTMH without vitreomacular separation. Macular structure parameters, including foveal base width (FBW), central foveolar thickness (CFT), central subfield thickness (CST), central subfield volume (CSV), and retinal artery trajectory (RAT), were measured using optical coherence tomography and fundus photography. These parameters were compared among different FTMH groups.
Results A total of 68 patients (39 women) with unilateral FTMH and 68 healthy controls were enrolled. The RAT of the lesioned eyes (0.19±0.06) and the healthy fellow eyes (0.14±0.04) were both smaller than those of the normal controls (0.37±0.14) (P<0.001 for both). The FBW of the healthy fellow eyes (446.8±98.2 µm) were significantly larger than those in the control group (338.4±80.6 µm, P<0.001). No significant differences in any macular parameters were noted among the three different types of FTMH.
Conclusions Patients with unilateral FTMH had a wider RAT in both the lesioned and healthy eyes, and a wider foveal base in their healthy fellow eyes than in normal controls. Such macular structure characteristics may be prone to macular hole formation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of National taiwan University Hospital gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Meeting presentation: APAO 2023, Kuala Lumpur, Malaysia.
Financial Support: None
Conflict of Interest: No conflicting relationship exists for any author
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
